Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: The risk-benefit balancing act

A. Tefferi

Research output: Contribution to journal › Editorial › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: The risk-benefit balancing act'. Together they form a unique fingerprint.